Evidence map›Paper›PMID 28512459›Full record

ArticleFrontiers in immunology2017

Maria Carmina Castiello, Francesca Pala, Lucia Sereni, Elena Draghici, Donato Inverso, Aisha V Sauer, Francesca Schena, Elena Fontana, Enrico Radaelli, Paolo Uva and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Maria Carmina CastielloSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Francesca PalaSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Lucia SereniSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Elena DraghiciSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Donato InversoDynamics of Immune Responses, Division of Immunology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Aisha V SauerSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Francesca SchenaLaboratory of Immunology and Rheumatic Disease, IGG, Genova, Italy.
Elena FontanaDepartment of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy.
Enrico RadaelliVIB11 Center for the Biology of Disease, Center for Human Genetics, KU Leuven, Leuven, Belgium.
Paolo UvaCRS4, Science and Technology Park Polaris, Pula, Italy.
Karla E Cervantes-LuevanoCellular Immunology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Federica BenvenutiCellular Immunology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Pietro L PolianiDepartment of Molecular and Translational Medicine, Pathology Unit, University of Brescia, Brescia, Italy.
Matteo IannaconeVita-Salute San Raffaele University, Milan, Italy.
Elisabetta TraggiaiLaboratory of Immunology and Rheumatic Disease, IGG, Genova, Italy.
Anna VillaSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Marita BosticardoSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico San RaffaeleInternational Centre for Genetic Engineering and Biotechnology · ITThe San Raffaele Telethon Institute for Gene Therapy · ITUniversity of Brescia · ITEnvironment Park · ITVIB-KU Leuven Center for Cancer Biology · BEVita-Salute San Raffaele University · IT

Funding

European Research Council 281648
6 · The paper itself

Abstract

Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency caused by mutations in the gene encoding the hematopoietic-specific WAS protein (WASp). WAS is frequently associated with autoimmunity, indicating a critical role of WASp in maintenance of tolerance. The role of B cells in the induction of autoreactive immune responses in WAS has been investigated in several settings, but the mechanisms leading to the development of autoimmune manifestations have been difficult to evaluate in the mouse models of the disease that do not spontaneously develop autoimmunity. We performed an extensive characterization of

Indexed as

apoptotic cellsautoimmunityB cellslymphocytic choriomeningitis virustoll-like receptorsWiskott–Aldrich syndrome

Identifiers

PMID28512459
PMCPMC5411424
OpenAlexW2610482898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.